Pfizer delays European review of Zeldox

PFE said that Sweden agreed to delay EU review of its MAA for its Zeldox ziprasidone dopamine D2 and serotonin 5HT2 receptor antagonist and serotonin receptor agonist to treat schizophrenia to conside...